- Global Pharma News & Resources

Evolva announces Chief Financial Officer to depart

Evolva Holding SA / Key word(s): Miscellaneous

02-March-2021 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.

Reinach, March 2, 2021 - Evolva announced today that André Pennartz, CFO of Evolva, is leaving the company for personal reasons with immediate effect. 

Oliver Walker, CEO of Evolva, said:«I'd like to thank André Pennartz for his contributions and wish him the best for his future.»

Oliver Walker will take on the role of CFO ad interim until a successor is appointed.

About Evolva
Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva's employees, half of which are women, are dedicated to make the best products that can contribute to health, wellbeing and sensory enjoyment. Find out more at

For Evolva multi media content, please visit:

Barbara Duci
Head of Investor and Corporate Relations
+41 61 485 2003
+41 79 739 2636

End of ad hoc announcement
Language: English
Company: Evolva Holding SA
Duggingerstrasse 23
4153 Reinach
Phone: +41 61 485 20 00
ISIN: CH0021218067
Valor: 2121806
Listed: SIX Swiss Exchange
EQS News ID: 1172252

End of Announcement EQS Group News Service

Editor Details

Last Updated: 02-Mar-2021